scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VACCINE.2018.03.015 |
P8608 | Fatcat ID | release_dybuxwyv4zbuvajwocwlsiqlne |
P698 | PubMed publication ID | 29550196 |
P2093 | author name string | Hui Lin | |
Guangming Zhong | |||
Yimou Wu | |||
Jianlin Chen | |||
Lingli Tang | |||
Cuiming Zhu | |||
P2860 | cites work | Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity | Q28075820 |
Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes | Q30355020 | ||
A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum | Q33606828 | ||
CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques | Q33620511 | ||
Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides | Q33706917 | ||
The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract | Q33727953 | ||
Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein | Q33731623 | ||
An outbreak of psittacosis at a veterinary school demonstrating a novel source of infection | Q33753457 | ||
Chlamydial colonization of multiple mucosae following infection by any mucosal route | Q33877422 | ||
Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae | Q34006511 | ||
Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract | Q34119475 | ||
Immunity to murine chlamydial genital infection | Q34124225 | ||
The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge | Q34163335 | ||
Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator | Q34445366 | ||
Role of secretory IgA in the mucosal sensing of commensal bacteria | Q34455427 | ||
Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice | Q34595830 | ||
Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum | Q34937975 | ||
Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. | Q35053935 | ||
Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology | Q35149009 | ||
Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection | Q35329016 | ||
In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract | Q35439847 | ||
A re-evaluation of the role of B cells in protective immunity to Chlamydia infection | Q35471373 | ||
Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility | Q35577108 | ||
Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway | Q35634194 | ||
Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility | Q35780883 | ||
Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested | Q35821202 | ||
What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion. | Q35843892 | ||
In Vivo and Ex Vivo Imaging Reveals a Long-Lasting Chlamydial Infection in the Mouse Gastrointestinal Tract following Genital Tract Inoculation | Q35947374 | ||
The Chlamydia muridarum Organisms Fail to Auto-Inoculate the Mouse Genital Tract after Colonization in the Gastrointestinal Tract for 70 days | Q36021473 | ||
VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells | Q36161076 | ||
Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection | Q36169344 | ||
Chlamydia trachomatis IgG3 seropositivity is associated with gastroschisis | Q36225709 | ||
Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. | Q36380500 | ||
A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection | Q36445638 | ||
The Chromosome-Encoded Hypothetical Protein TC0668 Is an Upper Genital Tract Pathogenicity Factor of Chlamydia muridarum | Q36513495 | ||
The contribution of Chlamydia-specific CD8⁺ T cells to upper genital tract pathology | Q36563801 | ||
OT-1 mice display minimal upper genital tract pathology following primary intravaginal Chlamydia muridarum infection | Q36810733 | ||
Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection | Q36846247 | ||
Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models | Q37087607 | ||
Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection | Q37114957 | ||
Intravenous Inoculation with Chlamydia muridarum Leads to a Long-Lasting Infection Restricted to the Gastrointestinal Tract | Q37129928 | ||
Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers | Q37148598 | ||
Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix | Q37335879 | ||
IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection | Q37345928 | ||
Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature | Q37555995 | ||
Chlamydia vaccine candidates and tools for chlamydial antigen discovery | Q37608309 | ||
Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression | Q37643363 | ||
Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum | Q37643910 | ||
Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection | Q37713214 | ||
Neutrophils are Central to Antibody-Mediated Protection against Genital Chlamydia | Q37833756 | ||
Distribution of Chlamydia trachomatis genotypes in neonatal conjunctivitis in Hungary | Q37833849 | ||
Chlamydia muridarum with Mutations in Chromosomal Genes tc0237 and/or tc0668 Is Deficient in Colonizing the Mouse Gastrointestinal Tract | Q37834015 | ||
Update on Chlamydia trachomatis Vaccinology | Q37834874 | ||
Retesting young STI clinic visitors with urogenital Chlamydia trachomatis infection in the Netherlands; response to a text message reminder and reinfection rates: a prospective study with historical controls | Q37839003 | ||
Outbreak of psittacosis in a group of women exposed to Chlamydia psittaci-infected chickens. | Q37840111 | ||
Rectal chlamydia infection in women at high risk of chlamydia attending Canberra Sexual Health Centre | Q37840724 | ||
Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics | Q37843232 | ||
Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics | Q37843611 | ||
Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. | Q37843778 | ||
Prevalence and molecular identification of Chlamydia abortus in commercial dairy goat farms in a hot region in Mexico. | Q37844558 | ||
An atypical CD8 T-cell response to Chlamydia muridarum genital tract infections includes T cells that produce interleukin-13. | Q37845143 | ||
Prevalence and correlates of rectal Chlamydia and gonorrhea among female clients at sexually transmitted disease clinics | Q37847572 | ||
Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials | Q37850545 | ||
Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®. | Q37851487 | ||
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia | Q37858116 | ||
The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment | Q37858995 | ||
Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village | Q37860150 | ||
Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection | Q37863975 | ||
Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum | Q37865891 | ||
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation | Q37881372 | ||
Chlamydia trachomatis-induced salpingitis in mice | Q37906450 | ||
A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis | Q37909549 | ||
Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges | Q38700182 | ||
The Boosting Potential of Bacteria in Cancer Immunotherapy | Q39352759 | ||
Atypical bacterial pneumonia in the HIV-infected population | Q40064046 | ||
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors | Q40673098 | ||
Immunity to Chlamydia trachomatis | Q43410249 | ||
Non-pathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection. | Q44059311 | ||
Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection | Q47547060 | ||
Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia | Q48512361 | ||
A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer | Q50044950 | ||
Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia | Q50135796 | ||
A Genital Infection-Attenuated Chlamydia muridarum Mutant Infects the Gastrointestinal Tract and Protects against Genital Tract Challenge | Q101216560 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2061-2068 | |
P577 | publication date | 2018-03-14 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Oral Chlamydia vaccination induces transmucosal protection in the airway. | |
P478 | volume | 36 |
Q92954185 | Antigen-Specific CD4+ T Cell-Derived Gamma Interferon Is Both Necessary and Sufficient for Clearing Chlamydia from the Small Intestine but Not the Large Intestine |
Q92500598 | Distinct Roles of Chromosome- versus Plasmid-Encoded Genital Tract Virulence Factors in Promoting Chlamydia muridarum Colonization in the Gastrointestinal Tract |
Q92283052 | The Plasmid-Encoded pGP3 Promotes Chlamydia Evasion of Acidic Barriers in Both Stomach and Vagina |
Search more.